424 related articles for article (PubMed ID: 22354305)
41. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
[TBL] [Abstract][Full Text] [Related]
42. Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.
Healey KR; Katiyar SK; Castanheira M; Pfaller MA; Edlind TD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3947-9. PubMed ID: 21628537
[TBL] [Abstract][Full Text] [Related]
43. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
44. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
45. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
46. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
[TBL] [Abstract][Full Text] [Related]
47. Detection of Echinocandin-Resistant
Bordallo-Cardona MÁ; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559139
[TBL] [Abstract][Full Text] [Related]
48. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.
Niimi K; Woods MA; Maki K; Nakayama H; Hatakenaka K; Chibana H; Ikeda F; Ueno K; Niimi M; Cannon RD; Monk BC
J Antimicrob Chemother; 2012 Jul; 67(7):1666-76. PubMed ID: 22514266
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
[TBL] [Abstract][Full Text] [Related]
50. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
Katiyar SK; Alastruey-Izquierdo A; Healey KR; Johnson ME; Perlin DS; Edlind TD
Antimicrob Agents Chemother; 2012 Dec; 56(12):6304-9. PubMed ID: 23027185
[TBL] [Abstract][Full Text] [Related]
51. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.
Arendrup MC; Garcia-Effron G; Lass-Flörl C; Lopez AG; Rodriguez-Tudela JL; Cuenca-Estrella M; Perlin DS
Antimicrob Agents Chemother; 2010 Jan; 54(1):426-39. PubMed ID: 19884370
[TBL] [Abstract][Full Text] [Related]
52. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
Desnos-Ollivier M; Bretagne S; Lortholary O; Dromer F;
Antimicrob Agents Chemother; 2022 May; 66(5):e0172521. PubMed ID: 35412354
[TBL] [Abstract][Full Text] [Related]
53. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Thompson GR; Wiederhold NP; Vallor AC; Villareal NC; Lewis JS; Patterson TF
Antimicrob Agents Chemother; 2008 Oct; 52(10):3783-5. PubMed ID: 18676885
[TBL] [Abstract][Full Text] [Related]
54. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.
Klotz U; Schmidt D; Willinger B; Steinmann E; Buer J; Rath PM; Steinmann J
Mycoses; 2016 May; 59(5):312-8. PubMed ID: 26806376
[TBL] [Abstract][Full Text] [Related]
55. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Moet GJ; Jones RN
J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424
[TBL] [Abstract][Full Text] [Related]
56. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Jones RN; Turnidge J; Diekema DJ
J Clin Microbiol; 2010 Jan; 48(1):52-6. PubMed ID: 19923478
[TBL] [Abstract][Full Text] [Related]
57. Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysis.
Bienvenu AL; Leboucher G; Picot S
Mycoses; 2019 Sep; 62(9):835-846. PubMed ID: 31077631
[TBL] [Abstract][Full Text] [Related]
58. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
Cheung YY; Hui M
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
[TBL] [Abstract][Full Text] [Related]
59. Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
McCarty TP; Lockhart SR; Moser SA; Whiddon J; Zurko J; Pham CD; Pappas PG
J Antimicrob Chemother; 2018 Jun; 73(6):1677-1680. PubMed ID: 29506044
[TBL] [Abstract][Full Text] [Related]
60. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Pfaller MA; Diekema DJ; Ostrosky-Zeichner L; Rex JH; Alexander BD; Andes D; Brown SD; Chaturvedi V; Ghannoum MA; Knapp CC; Sheehan DJ; Walsh TJ
J Clin Microbiol; 2008 Aug; 46(8):2620-9. PubMed ID: 18579718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
